Bet on these top-ranked stocks with rising P/E to realize outsized gains.

BILLERICA, Mass., May 05, 2020 -- Conformis, Inc. (NASDAQ: CFMS) announced today that it will host a webcast and conference call on Monday, May 11, 2020, at 4:30 p.m. Eastern.

Q4 2019 Conformis Inc Earnings Call

A Cambridge startup that already had $147 million in its pocket at the end of last year is returning the Paycheck Protection Program loan it received following nationwide criticism of how the funds were awarded.

With hospitals devoting nearly all their efforts to deal with the pandemic, elective procedures are being put on the backburner Continue reading...

Conformis, Inc. (CFMS) announced today that, due in large part to a loan made available to the Company under the Paycheck Protection Program (“PPP Loan”) offered by the U.S. Small Business Administration to qualified small businesses in response to the coronavirus (COVID-19) pandemic and the economic harm done to the Company’s business, the Company has accelerated its plan to return to full-time employment the vast majority of those employees who were furloughed on March 23, 2020. With the exception of a few employees who have separated from the Company in the normal course of business, the Company expects most of the furloughed employees to return to active employment as early as April 27, 2020.

Conformis, Inc. (CFMS) today announced that, due to the public health impact of the novel coronavirus outbreak and governmental restrictions limiting the number of people who may gather together, and to support the health and well-being of its stockholders, employees and communities, its 2020 annual meeting of stockholders, to be held on Monday, April 27, 2020 at 4:30 p.m. Eastern time, has been changed to a virtual meeting. Stockholders will be able to participate in this year’s Annual Meeting only via the virtual meeting. Stockholders are entitled to participate in the Annual Meeting if they were a stockholder at the close of business on February 27, 2020, the record date, or hold a legal proxy for the meeting provided by the stockholder’s bank, broker or nominee as of such record date.

Conformis, Inc. (CFMS), an orthopedic arthroplasty medical technology company, today announced proactive steps it is taking and planning to mitigate the negative financial and operational impacts of the coronavirus (COVID-19) pandemic. “Our core product areas of knee and hip surgery are being impacted in unprecedented ways by COVID-19,” said Mark Augusti, President and Chief Executive Officer. When combined with patients’ desire to self-isolate, we have seen a significant reduction in elective surgeries, including an almost complete shutdown of elective arthroplasty in many major cities across Europe and the United States.

BILLERICA, Mass., May 11, 2020 -- Conformis, Inc. (NASDAQ:CFMS), a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop,.

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...

Inside the top-ranked stocks that have been exhibiting rising P/E ratios.

Conformis, Inc. (CFMS), a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture, and sell joint replacement implants and instruments that are individually sized and shaped, and which the company refers to as personalized or individualized, to fit each patient’s unique anatomy, announced today that management will present at the Cowen 40th Annual Health Care Conference in Boston. The presentation is being made on Wednesday, March 4, 2020, from 11:20 a.m. to 11:50 a.m. EST at the Boston Marriott Copley Place hotel. Conformis is a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture, and sell joint replacement implants and instruments that are individually sized and shaped, which we refer to as personalized, individualized, or sometimes as customized, to fit each patient’s unique anatomy.

Q1 2020 Conformis Inc Earnings Call

ConforMIS (CFMS) delivered earnings and revenue surprises of 20.00% and -0.09%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?

Zacks.com featured highlights include: Amphastar Pharmaceuticals, ConforMIS, Kirkland Lake Gold, Cubic and Cimpress

BILLERICA, Mass., March 02, 2020 -- Conformis, Inc. (NASDAQ:CFMS), announced today financial results for the fourth quarter and year ended December 31, 2019. Q4 Summary Total.

Conformis, Inc. (CFMS) congratulates Dr. Malte Asseln for winning the prestigious Klee Prize 2020 for his dissertation and computer-and-image-based workflow on the optimization of knee implant design - “Morphological and Functional Analysis of the Knee Joint for Implant Design Optimization.” As reported in Medizin and Technik on May 6, 2020, Dr. Asseln’s results show that more knee implant sizes are required than are currently manufactured by off-the-shelf knee implant manufacturers, so patient-specific or better-tailored solutions are a promising approach to increase the 70 percent industry-wide patient satisfaction with artificial knee joints that he has observed.

Conformis, Inc. (CFMS) today announced that on April 17, 2020 the Company entered into a $4,719,800 promissory note with East West Bank (EWBC) under the Paycheck Protection Program (“PPP”) offered by the U.S. Small Business Administration (the "SBA") to mitigate the negative financial and operational impacts of the coronavirus (COVID-19) pandemic. In response to the coronavirus (COVID-19) pandemic, the Coronavirus Aid, Relief, and Economic Security Act (“CARES Act”) authorizes the SBA to make available low-interest rate loans to qualified small businesses under the PPP. According to the terms of the PPP, all or a portion of the loan may be fully forgiven if the funds are used for payroll costs (and at least 75% of the forgiven amount must have been used for payroll), interest on certain other outstanding debt, rent, and utilities.

ConforMIS (CFMS) delivered earnings and revenue surprises of -55.56% and -13.04%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

ConforMIS (CFMS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.